West Pharmaceutical Services (WST) Other Non-Current Assets (2009 - 2026)

West Pharmaceutical Services' Other Non-Current Assets history runs 18 years deep, the most recent figure standing at $81.3 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 15.81% year-over-year to $81.3 million; the TTM figure through Mar 2026 stood at $81.3 million (up 15.81% YoY), while the FY2025 annual figure was $80.1 million, up 7.81% from the prior year.
• Other Non-Current Assets came in at $81.3 million for Q1 2026 at West Pharmaceutical Services, up from $80.1 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $81.3 million in Q1 2026 to a low of $1.2 million in Q3 2022.
• A 5-year average of $50.4 million and a median of $49.4 million in 2022 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets slumped 92.94% in 2022 and surged 3133.33% in 2023, its largest moves.
• West Pharmaceutical Services' Other Non-Current Assets stood at $38.4 million in 2022, then tumbled by 44.53% to $21.3 million in 2023, then soared by 248.83% to $74.3 million in 2024, then increased by 7.81% to $80.1 million in 2025, then gained by 1.5% to $81.3 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $81.3 million, $80.1 million, and $75.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison